Medical Funds Management Limited

Global Equities Fund

MAS KiwiSaver SchemeAggressive

What the provider says about this fund

The Global Equities Fund usually invests only in growth assets. The Fund aims to provide higher returns over the long term. It is suitable for investors who are prepared to accept a higher level of investment risk to potentially achieve a higher return.

1-year return

12.57%

5-year return p.a.

6.66%

Total annual fee

0.98%

Fund size ($m)

174.6

Members

2,426

Inception date

1 October 2007

Risk indicator

The official Smart Investor risk indicator uses a scale from 1 to 7.

1
2
3
4
5
6
7
Lower riskHigher risk

Investment mix

Growth assets

97.92%

Income assets

2.08%

Asset classActualTargetAverage for Aggressive funds
Australasian shares30.46%30.00%28.28%
Commodities0.00%0.00%0.09%
International bonds0.00%0.00%0.17%
International shares67.44%70.00%59.89%
Listed property0.00%0.00%8.08%
New Zealand bonds0.00%0.00%0.17%
Unknown0.00%0.00%0.00%
Unlisted property0.00%0.00%0.17%

Top 10 holdings

RankAssetAsset classAsset typeCountry% of fund
1Fisher & Paykel Healthcare LtdSharesAustralasian EquitiesNZ5.04%
2Infratil LtdSharesAustralasian EquitiesNZ3.82%
3Apple IncSharesInternational EquitiesUS2.97%
4Nvidia CorpSharesInternational EquitiesUS2.78%
5Auckland International Airport LtdSharesAustralasian EquitiesNZ2.34%
6Alphabet Inc Class ASharesInternational EquitiesUS2.25%
7Microsoft CorpSharesInternational EquitiesUS2.19%
8Meridian Energy LimitedSharesAustralasian EquitiesNZ1.96%
9A2 Milk Company LtdSharesAustralasian EquitiesNZ1.95%
10JBWere Premium Custody Call Account - NZDCashCash and Cash EquivalentsNZ1.89%

Fees

0.98% total annual fee

Fee typeFeeCost per year on a $30,000 balanceAverage for Aggressive funds
Management fees0.89%$2670.71%
Other fees0.09%$270.08%
Membership fees0.00%$00.05%
Total combined fees0.98%$2940.85%

Yearly returns

Year endingFund returnAverage for Aggressive funds
31 March 201714.69%11.18%
31 March 20186.68%6.93%
31 March 20197.83%9.96%
31 March 2020-1.20%-6.59%
31 March 202135.33%35.19%
31 March 20224.54%3.36%
31 March 2023-3.52%-4.50%
31 March 202415.66%16.43%
31 March 20255.12%4.58%
31 March 202612.57%12.72%

Key personnel

NamePositionTime in role
Brendan O’donovanChair Investment Committee8 years, 9 months
Daniel MeadHead of Investment2 years, 8 months
Hayden GriffithsHead of Asset Allocation, JBWere29 years, 11 months
Phil BorkinSenior Strategist, JBWere7 years, 3 months
Rickey WardHead of Investment Strategy & Research, JBWere11 months